SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Sarcoma Alliance for Research through Collaboration
Sarcoma Alliance for Research through Collaboration
Washington University School of Medicine
Canadian Cancer Trials Group
Children's Oncology Group
OHSU Knight Cancer Institute
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)
SWOG Cancer Research Network
Novartis
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC